Evidence map›Paper›PMID 41495698›Full record

ArticleBMC infectious diseases2026

Secondary Aspergillus candidus infection in a lung cancer patient with a heavy smoking history: a case report.

Jie Yan, Xinyu Zhu, Jiaming Ye, Youqi Ji, Peng Nan, Yumei Ge

Abstract readCase Reports
In one paragraph

Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jie Yan *Department of Clinical Laboratory Medicine, Zhejiang Provincial People's Hospital Bijie Hospital (Bijie First People's Hospital), Bijie, 551700, Guizhou Province, China.
Xinyu Zhu *The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, 310053, People's Republic of China.
Jiaming Ye *Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, 310014, Zhejiang Province, China.
Youqi JiThe Second Affiliated Hospital of Zhejiang University of Chinese Medicine, Hangzhou, 310005, Zhejiang Province, China.
Peng NanLaboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, 310014, Zhejiang Province, China.
Yumei GeDepartment of Clinical Laboratory Medicine, Zhejiang Provincial People's Hospital Bijie Hospital (Bijie First People's Hospital), Bijie, 551700, Guizhou Province, China. 11218070@zju.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAspergillus candidus (A. candidus), while an uncommon clinical isolate, represents an emerging cause of severe invasive fungal disease, particularly among individuals with compromised immunity. Patients with hematologic or solid tumor malignancies-especially those with concomitant structural lung damage, such as resulting from long-term heavy smoking-are at heightened risk. CASE PRESENTATION: We describe a case of chronic pulmonary aspergillosis caused by A. candidus in a 66-year-old man with untreated lung cancer. The patient had a 40-year history of heavy smoking, with known chronic bronchitis and emphysema. Bilateral pulmonary nodules had been identified two years prior, for which he had declined intervention. He presented with complaints of cough, productive sputum, and worsening dyspnea. Chest imaging revealed progression of his underlying malignancy, accompanied by inflammatory changes. Bronchoalveolar lavage fluid was obtained and cultured; mycological analysis yielded colonies morphologically consistent with A. candidus, an identification subsequently confirmed through internal transcribed spacer (ITS) sequencing-the current gold standard for fungal speciation.

conclusionsTo our knowledge, this represents the first reported case of A. candidus infection in a treatment-naïve lung cancer patient with an extensive smoking history. It underscores the importance of considering this pathogen in heavily smoking-related lung cancer cases and highlights diagnostic and therapeutic challenges in this high-risk population.

Indexed as

AspergillusLung NeoplasmsPulmonary AspergillosisSmokingAgedBronchoalveolar Lavage FluidHumansMaleAspergillus candidusBronchoalveolar lavage fluidHeavy smoking historyITS sequencingUntreated lung cancer

Identifiers

PMID41495698
PMCPMC12790709

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.